Basics of Sales Rep Watching
Yesterday, as I was waiting in my doctor's office, at least seven pharmaceutical sales representatives came into and through the office, all within a 30-minute time span!That's about one rep every...
Acomplia Not for the Gun Totting Bikini Crowd
Sanofi's new anti-obesity pill is having problems gaining approval in the U.S. and is facing opposition in Germany and France, which have put limits on paying for the drug over there.This,...
Dong-A PharmTech: New Erectile Dysfunction Drug
This just came into my email inbox:"Dong-A PharmTech Co., Ltd. announced today that it has completed a 340 patient phase 2b 'at-home' clinical study for udenafil, its new long acting...
Spend, Spend, Spend Before the End, End, End
It's ironic that at the same time that experts and pharma insiders are talking about the golden age of DTC being behind us (see, for example, "Dead DTC Golden Goose and...
Dead DTC Golden Goose and Other Pharma Fears
Yesterday, I participated in a panel discussion at the iiBIG Pharmaceutical Sales & Marketing Executive Congress now going on at Caesars Hotel & Casino in Atlantic City, NJ. The panel's title...
Dining at Pharma’s Table
Last week, several bloggers met with J&J corporate PR people at a fancy NYC restaurant (see "Should Bloggers Dine at Pharma's Table?" also see my post here).I was invited, but could...
von Eschenbach & Gonzales: Two Birds in the Same Bush
What do FDA commish Andy von Eschenbach and Attorney General Alberto Gonzales have in common besides being "loyal Bushies?"Both believe it is within their right to fire employees for no other...
FDA Advisor Rule Loophole?
Yesterday, the FDA proposed a $50,000 limit on financial ties to industry of its advisory board members (see "FDA Proposes New, Tougher Procedures for Membership on Advisory Committees").But, as anyone can...
Rozerem Over There? Sic ’em Beav!
Abe and the Beav are off on a European vacation...or, should I say, invasion?Just when Europeans thought they were safe and had no problems sleeping soundly -- except, perhaps for the...
J&J, You’re No Elvis Presley!
According to TNS Media Intelligence, "the highest growth rate among the top 10 categories was registered by Pharmaceuticals which jumped 13.8 percent to $5.29 billion. This was due to...
